EUVIMEDEUVIMED entdecken
Crossref

Pain and heart rate variability in neonates receiving dexmedetomidine

Catarina Sevivas iD, Ruth Ibáñez, Melissa Fontalvo, María Luz Couce iD, Marta Camprubí-Camprubí iD

Journal of Perinatology · 2024

DOI: 10.1038/s41372-024-02053-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Perinatology, 2024. Verfasst von Catarina Sevivas und 4 weiteren Autor:innen. Beteiligte Einrichtung: Neonatology, BCNatal, Barcelona Center for Maternal Fetal and Neonatal Medicine, Hospital Sant Joan de Déu and Hospital Clinic, University of Barcelo…. Hauptthemen laut MEDLINE: Dexmedetomidine, Pain Measurement, Heart Rate, Infant, Premature. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

INTRODUCTION: Neonates in a NICU experience pain. Based on the cardiovascular and nociceptive systems link, a Newborn Infant Parasympathetic Evaluation (NIPE) monitor was designed to assess pain. The use of α2-agonists as analgesic-sedative drugs has increased in neonates. Given their effect on the autonomic system, we hypothesized that their use may alter NIPE's measurement capacity. METHODS: Data were prospectively collected. The included patients were evaluated using combined pain assessment systems. RESULTS: Sixteen newborns requiring sedoanalgesia underwent a total of 84 pain assessments. A good correlation was found between the NIPE-index and the COMFORT-neo and the crSO2 (cerebral regional oxygen saturation). No correlation was found in premature infants. By sedation group, the correlation remained in those receiving α2-agonist. CONCLUSION: NIPE is a reliable tool for pain assessment. Further studies in premature infants are needed. The use of α2-agonist does not alter the measuring capacity of NIPE. The correlation between NIPE-index and crSO2 was also demonstrated.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DexmedetomidinePain MeasurementHeart RateInfant, PrematureHumansInfant, NewbornProspective StudiesFemaleMalePainIntensive Care Units, NeonatalAnalgesics, Non-NarcoticHypnotics and SedativesAdrenergic alpha-2 Receptor Agonists

Substanzen

DexmedetomidineAnalgesics, Non-NarcoticHypnotics and SedativesAdrenergic alpha-2 Receptor Agonists

Autor:innen und Institutionen

  • Neonatology, BCNatal, Barcelona Center for Maternal Fetal and Neonatal Medicine, Hospital Sant Joan de Déu and Hospital Clinic, University of Barcelona, Barcelona, Spain. catarinaalexandra.sevivas@sjd.es.
  • Neonatology, Clinical University Hospital of Santiago de Compostela, Health Research Institute of Santiago de Compostela (IDIS), RICORS, Santiago de Compostela, Spain. catarinaalexandra.sevivas@sjd.es.
  • Neonatology, BCNatal, Barcelona Center for Maternal Fetal and Neonatal Medicine, Hospital Sant Joan de Déu and Hospital Clinic, University of Barcelona, Barcelona, Spain.
  • Neonatology, Clinical University Hospital of Santiago de Compostela, CIBERER, Health Research Institute of Santiago de Compostela (IDIS), RICORS, MetabERN: European Reference Network for Rare Hereditary Metabolic Disord…
  • Cardiovascular Research Group, Sant Joan de Déu Research Institute, Barcelona, Spain.

ORCID-Profile: Catarina Sevivas, María Luz Couce, Marta Camprubí-Camprubí

Zitieren

APA

Sevivas, C., Ibáñez, R., Fontalvo, M., Couce, M. L., & Camprubí-Camprubí, M. (2024). Pain and heart rate variability in neonates receiving dexmedetomidine. Journal of Perinatology. https://doi.org/10.1038/s41372-024-02053-8

Vancouver

Sevivas C, Ibáñez R, Fontalvo M, Couce ML, Camprubí-Camprubí M. Pain and heart rate variability in neonates receiving dexmedetomidine. Journal of Perinatology. 2024. doi:10.1038/s41372-024-02053-8

BibTeX
@article{Sevivas2024,
  author = {Sevivas, Catarina and Ibáñez, Ruth and Fontalvo, Melissa and Couce, María Luz and Camprubí-Camprubí, Marta},
  title = {Pain and heart rate variability in neonates receiving dexmedetomidine},
  journal = {Journal of Perinatology},
  year = {2024},
  doi = {10.1038/s41372-024-02053-8}
}
Kostenlos starten →